Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Gene therapy Stories

DNA Inserted 'Gently' Into Living Cells Using New High-tech Laser Method
2013-08-08 09:51:43

The Optical Society Technique offers greater-than-ever control of essential gene therapy and genetic engineering method The applications of gene therapy and genetic engineering are broad: everything from pet fish that glow red to increased crop yields worldwide to cures for many of the diseases that plague humankind. But realizing them always starts with solving the same basic scientific question -- how to "transfect" a cell by inserting foreign DNA into it. Many methods already exist...

2013-08-08 08:31:02

LOS ANGELES, Aug. 8, 2013 /PRNewswire/ -- Kite Pharma Inc. (Kite), a clinical stage biotechnology company focused on developing engineered autologous T cell therapy (eACT) products for cancer, today announced the appointment of three leading experts in the areas of immunotherapy, chimeric antigen receptor (CAR) technology, and gene therapy to its Scientific Advisory Board (SAB). (Logo: http://photos.prnewswire.com/prnh/20130513/MM13332LOGO) "Kite is fortunate to attract these world-leading...

2013-07-30 12:29:13

DUBLIN, July 30, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/4p5wn9/drug_delivery_in) has announced the addition of a new report "Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies [http://www.researchandmarkets.com/research/4p5wn9/drug_delivery_in ]" to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The delivery of drugs to central nervous system (CNS)...

2013-07-30 08:33:13

- MYDICAR When Inhaled May Restore Function of SERCA2a Enzyme in the Lungs to Reverse Deadly PAH Condition - SAN DIEGO, July 30, 2013 /PRNewswire/ -- Celladon Corporation, a clinical-stage biotechnology company committed to applying its first-mover, leadership position in the field of SERCA enzymes to transform the lives of patients with important, life-threatening diseases, announced today that an international team of researchers led by investigators at the Cardiovascular Research Center...

Genetic Mutation Linked Congenital Heart Defect
2013-07-30 08:39:37

April Flowers for redOrbit.com - Your Universe Online A team of scientists from The Research Institute at Nationwide Children'sHospital has found a mutation in a gene crucial to normal heart development could play a role in some types of congenital heart defects - the most common birth defect in the US. The findings were published in the journal Human Mutation and could help narrow the search for genes that contribute to this genetic defect, which affects as many as 40,000 newborns a year....

2013-07-26 12:10:38

Duke researchers have devised a way to quickly and easily target and tinker with any gene in the human genome. The new tool, which builds on an RNA-guided enzyme they borrowed from bacteria, is being made freely available to researchers who may now apply it to the next round of genome discovery. The new method also has obvious utility for gene therapy and for efforts to reprogram stem or adult cells into other cell types – for example, to make new neurons from skin cells....

2013-07-23 08:29:13

President and Chief Scientific Officer of NeoStem Subsidiary Progenitor Cell Therapy Joins Leading Clinicians, Developers, and Consultants in the High Growth Regenerative Medicine Market BOTHELL, Wash., July 23, 2013 /PRNewswire/ -- BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced that...

2013-07-22 13:07:16

A recent study published in the Neural Regeneration Research (Vol. 8, No. 17, 2013) injected recombinant lentivirus carrying enhanced green fluorescent protein and the target gene Atoh1 into the cochlea of normal rats using a postauricular approach via the round window membrane. After 30 days, recombinant lentivirus was shown to have no impact on the hair cell numbers and auditory functions, infect hair and supporting cells, and promote supporting cells to transdifferentiate into hair cells....

2013-07-16 16:24:28

DUBLIN, July 16, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/6pvm54/personalized) has announced the addition of a new report "Personalized Medicine - Scientific and Commercial Aspects" [http://www.researchandmarkets.com/research/6pvm54/personalized ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This updated 2013 report now features even more company profiles and collaborations!...

2013-07-16 16:24:16

DUBLIN, July 16, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/dhdp3r/cell_therapy) has announced the addition of Jain PharmaBiotech's new report "Cell Therapy - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/dhdp3r/cell_therapy ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report describes and evaluates cell therapy technologies and methods, which...